Shin Yee Hui

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Inflammatory Response

Epstein Barr Virus

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Man Wu, Pok Man Hau, Linxian Li, Chi Man Tsang, Yike Yang, Aziz Taghbalout, Grace Tin-Yun Chung, Shin Yee Hui, Wing Chung Tang, Nathaniel Jillette, Jacqueline Jufen Zhu, Horace Hok Yeung Lee, Ee Ling Kong, Melissa Sue Ann Chan, Jason Ying-Kuen Chan, Brigette Buig Yue Ma, Mei-Ru Chen, Charles Lee, Ka-Fai To, Albert Wu Cheng, Kwok-Wai Lo
Synthetic BZLF1-targeted transcriptional activator for efficient lytic induction therapy against EBV-associated epithelial cancers. Nature communications 15 (1) (2024)
Man Wu, Pok Man Hau, Linxian Li, Chi Man Tsang, Yike Yang, Aziz Taghbalout, Grace Tin-Yun Chung, Shin Yee Hui, Wing Chung Tang, Nathaniel Jillette, Jacqueline Jufen Zhu, Horace Hok Yeung Lee, Ee Ling Kong, Melissa Sue Ann Chan, Jason Ying-Kuen Chan, Brigette Buig Yue Ma, Mei-Ru Chen, Charles Lee, Ka-Fai To, Albert Wu Cheng, Kwok-Wai Lo
Synthetic BZLF1-targeted transcriptional activator for efficient lytic induction therapy against EBV-associated epithelial cancers. Nature communications 15 (1) (2024)
Man Wu, Pok Man Hau, Linxian Li, Chi Man Tsang, Yike Yang, Aziz Taghbalout, Grace Tin-Yun Chung, Shin Yee Hui, Wing Chung Tang, Nathaniel Jillette, Jacqueline Jufen Zhu, Horace Hok Yeung Lee, Ee Ling Kong, Melissa Sue Ann Chan, Jason Ying-Kuen Chan, Brigette Buig Yue Ma, Mei-Ru Chen, Charles Lee, Ka-Fai To, Albert Wu Cheng, Kwok-Wai Lo
Synthetic BZLF1-targeted transcriptional activator for efficient lytic induction therapy against EBV-associated epithelial cancers. Nature communications 15 (1) (2024)
Man Wu, Pok Man Hau, Linxian Li, Chi Man Tsang, Yike Yang, Aziz Taghbalout, Grace Tin-Yun Chung, Shin Yee Hui, Wing Chung Tang, Nathaniel Jillette, Jacqueline Jufen Zhu, Horace Hok Yeung Lee, Ee Ling Kong, Melissa Sue Ann Chan, Jason Ying-Kuen Chan, Brigette Buig Yue Ma, Mei-Ru Chen, Charles Lee, Ka-Fai To, Albert Wu Cheng, Kwok-Wai Lo
Synthetic BZLF1-targeted transcriptional activator for efficient lytic induction therapy against EBV-associated epithelial cancers. Nature communications 15 (1) (2024)